Kamyar D Kalantar-Zadeh, MD, PhD

Kamyar Kalantar-Zadeh, MD, PhD

Investigator, The Lundquist Institute
Professor of Medicine, Pediatrics and Public Health and Chief of Nephrology, UCI School of Medicine
Adjunct Professor of Epidemiology, UCLA Fielding School of Public Health


Kidney disease outcome & epidemiology

Research Description

Dr. Kalantar has conducted research on kidney disease outcome and epidemiology, cardiovascular risks in CKD, malnutrition and wasting in chronic diseases, inflammation and cachexia, diabetes and obesity, renal osteodystrophy and mineral disorders, sodium and potassium disarrays, anemia and iron deficiency, disparities and quality of life in CKD, and acid-base disorders.


  • MD, 1991,Medicine, University of Bonn, German
  • MPH, 1999, Public Health, University of California, Berkeley
  • PhD, 2004, Epidemiology, University of California, Berkeley

Recent and/or Significant Publications

Kalantar-Zadeh K, Streja E, Kovesdy CP, Noori N, Oreopoulos A, Jing J, Nissenson AR, Krishnan M, Kopple JD, Mehrotra R, Anker SD. Obesity Paradox and Mortality-Predictability of Surrogates of Body Size and Muscle Mass in Hemodialysis Patients. Mayo Clinic Proc 2010; (85): 991-1001.
Kovesdy CP, Ahmadzadeh S, Anderson JE, and Kalantar-Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008; 168(4): 397-403.
A1C and Survival in Maintenance Hemodialysis Patients Kamyar Kalantar-Zadeh, Joel D. Kopple, Deborah L. Regidor, Jennie Jing, Christian S. Shinaberger, Jason Aronovitz, Charles J. McAllister, David Whellan, Kumar Sharma Diabetes Care May 2007, 30 (5) 1049-1055.

Institute News